GlassScriptPhysician profile
Peter J Tucker
NPI 1336149442
$2,633.00
in general payments reported to CMS, 2019-2025
25 companies · $541 in 2025
The $541 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $371 · 2021: $622 · 2022: $151 · 2023: $203 · 2024: $24.74 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $619.14 | 2023-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Astellas Pharma US INC | $531.04 | 2019-2022 | |
| Allergan, INC. | $264.07 | 2019-2021 | |
| Neotract INC. | $170.08 | 2019-2020 | |
| Abbvie INC. | $154.55 | 2019-2023 | Lupron Depot |
| Biogen, INC. | $124.80 | 2019 | |
| Coloplast Corp | $113.50 | 2021-2025 | Speedicath |
| Teleflex LLC | $102.25 | 2021-2023 | Urolift |
| Boston Scientific Corporation | $67.79 | 2019 | |
| Omeros Corporation | $55.22 | 2020 | |
| Urovant Sciences INC | $55.03 | 2021 | |
| Medtronic USA, INC. | $50.15 | 2019-2020 | |
| Medtronic, INC. | $45.70 | 2021-2023 | Interstim |
| Pfizer INC. | $42.55 | 2019-2021 | |
| Myovant Sciences INC. | $29.00 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $28.88 | 2019 | |
| Endo Pharmaceuticals INC. | $28.18 | 2020-2021 | |
| Palette Life Sciences, INC. | $25.80 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $23.90 | 2021 | |
| Urogen Pharma, INC. | $21.88 | 2022 | |
| Merck Sharp & Dohme LLC | $19.10 | 2021 | |
| Photocure INC | $18.62 | 2019 | |
| Amgen INC. | $14.58 | 2019 | |
| Myriad Genetic Laboratories, INC. | $13.78 | 2021 | |
| Ferring Pharmaceuticals INC. | $13.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.